The effect of Synbiotics in humans on biomarkers of risk for colorectal cancer (CRC)

Phase 4

Completed

• Conditions: Bowel cancer; Cancer - Bowel - Back passage (rectum) or large bowel (colon)

• Registration Number: ACTRN12606000115538
• Lead Sponsor: Professor Graeme Young MD, FRACP

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-03-31
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Healthy, with no active bowel disease, or with a previous history of adenoma removal.

Exclusion Criteria

Evidence of any active mucosal bowel disease, eg colitis, or of malabsorption.Intolerance to high-fibre foods. Any perceived contraindication to consumption of the test products.

Study & Design

• Study Type: Interventional
• Study Design: Not specified